Privia Health Group (NASDAQ:PRVA) Upgraded to Strong-Buy by Baird R W

Baird R W upgraded shares of Privia Health Group (NASDAQ:PRVA – Free Report) to a strong-buy rating in a report issued on Thursday morning, Zacks.com reports. A number of other research firms have also recently commented on PRVA. Canaccord Genuity Group lowered their target price on shares of Privia Health Group from $37.00 to $26.00 […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,United States ,America ,David Mountcastle ,Robertw Baird ,Invesco Ltd ,Jpmorgan Chase Co ,Canaccord Genuity Group ,Privia Health Group Inc ,Securities Exchange Commission ,Wellington Management Group ,Nasdaq ,Vanguard Group Inc ,Privia Health Group ,Riverbridge Partners ,News Ratings For Privia Health Group Daily ,Privia Health Group Company Profile ,Analyst Recommendations For Privia Health Group ,Institutional Trading Of Privia Health Group ,Privia Health Group Stock Performance ,Free Report ,Genuity Group ,Moderate Buy ,Health Group ,Get Free Report ,Exchange Commission ,Privia Health ,Management Group ,Avidity Partners Management ,Partners Management ,Privia Health Group Daily ,